🤯 Picked by our AI, this stock rallied more than Nvidia this month, yielding 94% since MarchSee the stock

GE HealthCare announces secondary offering of 13 million shares

EditorNatashya Angelica
Published 03/12/2024, 05:12 PM
© Reuters.

CHICAGO - GE HealthCare (NASDAQ:GEHC) Technologies Inc. (NASDAQ:GEHC), a prominent player in the medical technology and diagnostics field, has initiated a secondary public offering of 13 million shares of its common stock. Notably, the company itself will not be selling any shares nor receiving proceeds from this transaction.

Before the offering's close, General Electric Company (NYSE:GE) is expected to engage in a debt-for-equity swap with Morgan Stanley Bank, N.A., the affiliate of Morgan Stanley & Co (NYSE:MS). LLC, which is designated as the selling stockholder. Post this exchange, Morgan Stanley & Co. LLC plans to sell the acquired GE HealthCare shares to the underwriter.

The underwriter has been granted an option to purchase additional shares, which if exercised, will be settled by March 28, 2024. Morgan Stanley is serving as the sole book-running manager for the offering, proposing to sell the shares on The Nasdaq Stock Market, over-the-counter market, or through negotiated transactions.

Investors can access the offering documents, which include a prospectus, through the SEC's EDGAR database or directly from Morgan Stanley & Co. LLC. It's important to note that this press release does not constitute an offer to sell or a solicitation of an offer to buy the securities in any state or jurisdiction where such an offer would be unlawful.

GE HealthCare, with over a century of service to the healthcare sector, aims to enhance the efficiency of hospitals and the effectiveness of clinicians through its integrated solutions and services. The company, which operates a $19.6 billion business with 51,000 employees, focuses on advancing personalized and connected care.

Investors are cautioned that this release contains forward-looking statements that involve risks and uncertainties, including those related to the offering's size, timing, and results. These statements are based on current management expectations and are subject to factors that may lead to actual results differing materially.

These factors are detailed in the company's filings with the SEC, including a registration statement filed on February 15, 2024.

This news article is based on a press release statement from GE HealthCare Technologies Inc.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.